Crestor Flat Pricing Helps AstraZeneca Secure Coverage For 50% Of Lives

AstraZeneca's flat pricing model for Crestor has helped the company secure positions on managed care formularies that apply to more than 50% of covered lives, VP-Primary Care Cardiovascular Adele Gulfo said Oct 2